Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

New vaccine technology may prove beneficial for treating IGF-1 responsive disorders

Braasch Biotech LLC announces its lead vaccine for Obesity, Growth Hormone Deficiencies may have beneficial use for numerous IGF-1 responsive disorders such as diabetes, heart disease and Rett Syndrome based on initial preclinical testing in a mouse model.

1 Sep 2009

High-fiber cereals make progress in taste

Consumer Reports evaluated 18 high-fiber cereals and found seven especially flavorful choices. The report notes that most Americans can stand to double their intake of fiber which can help control appetite and weight, and might help lower the risk of heart disease and type 2 diabetes.

1 Sep 2009

Study reveals that low carbohydrate diet delayed the need for antihyperglycemic drug therapy in type 2 diabetic patients

A study published in Annals of Internal Medicine found that compared with a low-fat diet, a low-carbohydrate Mediterranean-style diet led to more favorable changes in glycemic control and coronary risk factors and delayed the need for antihyperglycemic drug therapy for overweight patients with newly-diagnosed type 2 diabetes.

1 Sep 2009

New molecular sensor could identify zinc-related diseases

Scientists have developed a new molecular sensor that can reveal the amount of zinc in cells, which could tell us more about a number of diseases, including type 2 diabetes. The research, published today in Nature Methods, opens the door to the hidden world of zinc biology by giving scientists an accurate way of measuring the concentration of zinc and its location in cells for the first time.

30 Aug 2009

U.S. FDA agrees to the study design for cardiovascular outcomes trial of alogliptin

Takeda Pharmaceutical Company Limited ("Takeda") and Takeda Global Research & Development Center, Inc., a wholly owned United States (U.S.) subsidiary, today jointly announced that the latter has received notification that the U.S. Food and Drug Administration (FDA) has agreed to the study design for a cardiovascular (CV) outcomes trial titled EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome) for alogliptin, a selective dipeptidyl peptidase IV inhibitor under investigation for the treatment of type 2 diabetes as an adjunct to diet and exercise.

28 Aug 2009

The Research Partnership study reveals that diabetes can have a major effect on people's lives

A new research study carried out by The Research Partnership reveals that living with diabetes can have a major effect on people's lives, with just under half (44%) of type 2 patients reporting that the condition has impacted on either their ability or their desire to have sex.

28 Aug 2009

New genetic mechanism to control body's fat-building process identified

At a time of alarming increases in obesity and associated diseases -- and fiery debates about the cost of health care -- a UCF research team has identified a new genetic mechanism that controls the body's fat-building process.

27 Aug 2009

GI Dynamics to present additional results of mechanisms of actions clinical study

GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that additional results from a previously reported clinical study regarding mechanisms of action will be presented on Saturday, August 29, 2009 by Manoel Galvao Neto, M.D., scientific coordinator, Gastro Obeso Center, Sao Paulo, Brazil and lead investigator for the study, at the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) 14th World Congress in Paris, France.

27 Aug 2009

Polycystic ovary syndrome in women can be relieved by acupuncture and exercise

Polycystic ovary syndrome, a common condition among women, can be relieved by the use of acupuncture and exercise. This has been shown by a recent study at the Sahlgrenska Academy, University of Gothenburg, Sweden.

27 Aug 2009

New technique for diabetes treatment may be in the offing

An exploration of the molecular links between insulin resistance and inflammation may have revealed a novel target for diabetes treatment, say scientists at the John G. Rangos Sr. Research Center, Children's Hospital of Pittsburgh of UPMC. Their findings were published earlier this month in the online version of Diabetes, one of the journals of the American Diabetes Association.

27 Aug 2009

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Amgen today announced that in a large, randomized, double-blind, placebo-controlled, Phase 3 study of patients with chronic kidney disease (CKD) (not requiring dialysis), anemia and type-2 diabetes (the Trial to Reduce Cardiovascular Endpoints with Aranesp((R)) Therapy, or TREAT), treatment of anemia with Aranesp((R) )(darbepoetin alfa) to a hemoglobin target of 13 g/dL had no statistically significant effect on either of two primary endpoints compared with placebo treatment.

26 Aug 2009

Studies reveal that obese people are at greater risk for developing Alzheimer's disease

Obesity is on a rampage, with the World Health Organization pegging the numbers at more than 300 million worldwide, with a billion more overweight. With obesity comes the increased risk for cardiovascular disease, Type II diabetes, and hypertension.

25 Aug 2009

New study reveals that mild glucose intolerance in pregnancy may relate to risk of heart disease

Mild glucose intolerance in pregnancy may be an early identifier of women who are at increased risk of heart disease in the future, found a new study http://www.cmaj.ca/press/cmaj090569.pdf published in CMAJ (Canadian Medical Association Journal) www.cmaj.ca.

25 Aug 2009

The Center for Health Value Innovation to support the National Diabetes Goal

The Center for Health Value Innovation, the nation’s premier information exchange for value-based design, today joined with other non-profits, healthcare provider groups, universities, government officials, and corporations to fully support the National Diabetes Goal (NDG) which aims to increase awareness and improve the management of type 2 Diabetes to the 45 percent of Americans at risk.

24 Aug 2009

Diabetics can reduce the risk of cardiovascular disease by increasing vitamin D levels

Low levels of vitamin D are known to nearly double the risk of cardiovascular disease in patients with diabetes, and researchers at Washington University School of Medicine in St. Louis now think they know why.

24 Aug 2009

Takeda Canada reacquires commercial rights for an oral type 2 diabetic treatment drug

Takeda Canada, Inc. announced that it has reacquired the Canadian commercial rights to ACTOS(R) (pioglitazone HCl), an oral treatment for type 2 diabetes, from Eli Lilly Canada Inc. Takeda, the discoverer of ACTOS, licensed the drug to Lilly as part of a worldwide agreement in 1999.

21 Aug 2009

Wheat-free diet reduces the incidence of diabetes

Scientists at the Ottawa Hospital Research Institute and the University of Ottawa have discovered what may be an important clue to the cause of type 1 diabetes. Dr. Fraser Scott and his team tested 42 people with type 1 diabetes and found that nearly half had an abnormal immune response to wheat proteins. The study is published in the August 2009 issue of the journal Diabetes.

21 Aug 2009

Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: Population-based cohort study

Rosiglitazone, a drug used to treat type 2 diabetes, is associated with an increased risk of heart failure and death among older patients compared to a similar drug (pioglitazone), concludes a study published on bmj.com today.

20 Aug 2009

Nutrisystem's 28-Day program maintains an affordable per-meal cost

Nutrisystem, Inc., a leading provider of weight management products and services that are delivered directly to the customers' doors, announced today that its popular 28-Day Nutrisystem Select program now includes an additional week of delicious fresh-frozen entrees - all for the same low monthly cost.

20 Aug 2009

Surgeons of BMI of Texas selected to host a preceptorship for using REALIZE Adjustable Gastric Band

The Bariatric Medical Institute of Texas (“BMI of Texas”) today announced surgeons Mickey Seger and Terive Duperier have been selected by Ethicon Endo-Surgery, Inc. as one of the five training sites in the U.S. to host a preceptorship for the Ethicon Endo-Surgery REALIZE™ Adjustable Gastric Band.

20 Aug 2009

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

New vaccine technology may prove beneficial for treating IGF-1 responsive disorders

High-fiber cereals make progress in taste

Study reveals that low carbohydrate diet delayed the need for antihyperglycemic drug therapy in type 2 diabetic patients

New molecular sensor could identify zinc-related diseases

U.S. FDA agrees to the study design for cardiovascular outcomes trial of alogliptin

The Research Partnership study reveals that diabetes can have a major effect on people's lives

New genetic mechanism to control body's fat-building process identified

GI Dynamics to present additional results of mechanisms of actions clinical study

Polycystic ovary syndrome in women can be relieved by acupuncture and exercise

New technique for diabetes treatment may be in the offing

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Studies reveal that obese people are at greater risk for developing Alzheimer's disease

New study reveals that mild glucose intolerance in pregnancy may relate to risk of heart disease

The Center for Health Value Innovation to support the National Diabetes Goal

Diabetics can reduce the risk of cardiovascular disease by increasing vitamin D levels

Takeda Canada reacquires commercial rights for an oral type 2 diabetic treatment drug

Wheat-free diet reduces the incidence of diabetes

Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: Population-based cohort study

Nutrisystem's 28-Day program maintains an affordable per-meal cost

Surgeons of BMI of Texas selected to host a preceptorship for using REALIZE Adjustable Gastric Band

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in